.

From the Blue Ridge Institute for Medical Research (BRIMR.ORG)

..

Ranking Tables of NIH Funding to US Medical Schools in 2006-2011

.

For 2012, click here (Direct plus indirect costs but excluding R & D contracts and ARRA awards)

For 2011, click here (Direct plus indirect costs but excluding R & D contracts and ARRA awards)

For 2010, click here (Direct plus indirect costs but excluding R & D contracts and ARRA awards)
.

For 2009, click here (Direct plus indirect costs including $194 million in R & D contracts but excluding ARRA awards)

.

For 2009, click here (Direct plus indirect costs but excluding R & D contracts and ARRA awards)

For 2008, click here (Direct plus indirect costs including R & D contracts)
For 2007, click here (Direct plus indirect costs including R & D contracts)
For 2006, click here (Direct plus indirect costs including R & D contracts)
---------------------------------------------------------------------------------------------------
There are three kinds of lies: lies, damned lies, and statistics.a saying popularised by Mark Twain
Please do not shoot the pianist. He is doing his best. Oscar Wilde
En principle, oui. A French expression for non. Walter J. Moore
    The information contained in the Award files was obtained from the Research Portfolio Online Reporting Tool (RePORT) from the National Institutes of Health at http://report.nih.gov/award/trends/AggregateData.cfm. For reasons that are unclear, the Mayo Clinic is not designated as a School of Medicine and its awards are not attributed to specific departments. However, BRIMR has included the Mayo Clinic in the Medical School rankings from data included in the All Organizations file. This file was also used to calculate the rankings for all Institutions, Cities, Principal Investigators, and other Health Sciences Schools. Please report any discrepancies between the Blue Ridge Institute files and the NIH files to Webmaster@brimr.org. The Award Data correspond to the US Government fiscal year. Awards and R&D contracts for 2010 correspond to those granted from 1 October 2009-30 September 2010. 

     It is difficult, if not impossible, to summarize accurately department, medical school, and university allocations in brief tables. Bona fide medical school faculty may have their grants credited to hospitals thereby leading to an underestimate of medical school funding. Harvard Medical School, for example, has 17 teaching hospitals. These include Beth Israel Deaconess ($129 million in NIH funding in 2012), Brigham and Women's ($332 million), Boston Children's ($122 million), Dana-Farber ($124 million), and Massachusetts General Hospital ($345 million). Including these awards would increase the rank of Harvard Medical School. In contrast, some medical schools are credited  with grants to non-traditional medical school departments including biology, chemistry, psychology, and physics.

     There are additional considerations. The NIH combines diagnostic and therapeutic radiology (Radiation-Diagnostic/Oncology) into a single category, whereas these entities may represent separate departments. BRIMR catalogues these under Radiology. Moreover, a combined department (e.g., Department of Physiology and Pharmacology) will appear in only one category and skew the rankings for that department. The NIH files specify a single Principal Investigator (PI) so that a grant to multiple PI's and co-PIs cannot be credited to multiple departments. Click here to go to an NIH site for additional information. 

     The ≈ $11 billion awarded to medical schools accounts for nearly half of the $23 billion awarded in extramural NIH funding. However, data for recent R & D contracts, which historically account for about 10% of NIH extramural funding, does not attribute awards to specific departments nor to specific Medical Schools. These awards are not included in our reports from 2012-2012. Of the ≈ $2 billion in R and D contracts, less than $200 million has been awarded to Schools of Medicine. 

The Blue Ridge Institute for Medical Research is a Federal tax exempt 501(c)(3) non-profit organization incorporated in the State of North Carolina on 24 March 2006 (EIN 20-4665742; DLN 17053144012016).

USFDA approved protein kinase inhibitors

BRIMR Research Goals

 News Items

Publications/Reprints

Life Science Sketches and Commentary

Humor from BRIMR

BRIMR Officers and Directors

Book and Journal covers

Western North Carolina Photos
BRIMR Bylaws Common Sense Health Tips BRIMR in the Wall Street Journal
 

Home

Created on14 February 2009 and this page was updated 16 December 2012

Visitors since 7 August 2010